Genetic diagnosis in pediatric cardiomyopathy

Clinical application and research perspectives

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

There has been tremendous growth in the application of genetics to the clinical practice of pediatric cardiomyopathy. The identification of the genetic basis for cardiomyopathies is important for establishing a causal diagnosis, providing definitive identification of at risk family members, and providing cost-effective screening and surveillance. Additional research is needed to better understand the genetic heterogeneity of cardiomyopathy in children, the implications of specific genotypes, the best approach to cardiac surveillance and genetic testing, and the utility of genotyping for individual risk stratification. As the technology for evaluation of the human genome continues to improve, there is an increasing need for assessment of clinical relevance and utility. This is coupled with an ongoing need for education and training of professionals to interpret and implement genomics in a clinical setting.

Original languageEnglish (US)
Pages (from-to)99-102
Number of pages4
JournalProgress in Pediatric Cardiology
Volume31
Issue number2
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Cardiomyopathies
Pediatrics
Research
Professional Education
Genetic Heterogeneity
Needs Assessment
Genetic Testing
Human Genome
Genomics
Genotype
Technology
Costs and Cost Analysis
Growth

Keywords

  • Cardiomyopathy
  • Genetic testing
  • Mutation
  • Pediatric
  • Sequencing

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Genetic diagnosis in pediatric cardiomyopathy : Clinical application and research perspectives. / Ware, Stephanie.

In: Progress in Pediatric Cardiology, Vol. 31, No. 2, 05.2011, p. 99-102.

Research output: Contribution to journalArticle

@article{c725be8b98544e879f8ed9abb1f1cf40,
title = "Genetic diagnosis in pediatric cardiomyopathy: Clinical application and research perspectives",
abstract = "There has been tremendous growth in the application of genetics to the clinical practice of pediatric cardiomyopathy. The identification of the genetic basis for cardiomyopathies is important for establishing a causal diagnosis, providing definitive identification of at risk family members, and providing cost-effective screening and surveillance. Additional research is needed to better understand the genetic heterogeneity of cardiomyopathy in children, the implications of specific genotypes, the best approach to cardiac surveillance and genetic testing, and the utility of genotyping for individual risk stratification. As the technology for evaluation of the human genome continues to improve, there is an increasing need for assessment of clinical relevance and utility. This is coupled with an ongoing need for education and training of professionals to interpret and implement genomics in a clinical setting.",
keywords = "Cardiomyopathy, Genetic testing, Mutation, Pediatric, Sequencing",
author = "Stephanie Ware",
year = "2011",
month = "5",
doi = "10.1016/j.ppedcard.2011.02.006",
language = "English (US)",
volume = "31",
pages = "99--102",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Genetic diagnosis in pediatric cardiomyopathy

T2 - Clinical application and research perspectives

AU - Ware, Stephanie

PY - 2011/5

Y1 - 2011/5

N2 - There has been tremendous growth in the application of genetics to the clinical practice of pediatric cardiomyopathy. The identification of the genetic basis for cardiomyopathies is important for establishing a causal diagnosis, providing definitive identification of at risk family members, and providing cost-effective screening and surveillance. Additional research is needed to better understand the genetic heterogeneity of cardiomyopathy in children, the implications of specific genotypes, the best approach to cardiac surveillance and genetic testing, and the utility of genotyping for individual risk stratification. As the technology for evaluation of the human genome continues to improve, there is an increasing need for assessment of clinical relevance and utility. This is coupled with an ongoing need for education and training of professionals to interpret and implement genomics in a clinical setting.

AB - There has been tremendous growth in the application of genetics to the clinical practice of pediatric cardiomyopathy. The identification of the genetic basis for cardiomyopathies is important for establishing a causal diagnosis, providing definitive identification of at risk family members, and providing cost-effective screening and surveillance. Additional research is needed to better understand the genetic heterogeneity of cardiomyopathy in children, the implications of specific genotypes, the best approach to cardiac surveillance and genetic testing, and the utility of genotyping for individual risk stratification. As the technology for evaluation of the human genome continues to improve, there is an increasing need for assessment of clinical relevance and utility. This is coupled with an ongoing need for education and training of professionals to interpret and implement genomics in a clinical setting.

KW - Cardiomyopathy

KW - Genetic testing

KW - Mutation

KW - Pediatric

KW - Sequencing

UR - http://www.scopus.com/inward/record.url?scp=79955474373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955474373&partnerID=8YFLogxK

U2 - 10.1016/j.ppedcard.2011.02.006

DO - 10.1016/j.ppedcard.2011.02.006

M3 - Article

VL - 31

SP - 99

EP - 102

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

IS - 2

ER -